Mar 9, 2016 | Research News, Technology Updates
Senseonics’ Eversense: 90-day Implanted CGM Enters US Pivotal Trial www.DiaTribe.org, 2/26/2016 This pivotal trial will evaluate the accuracy and safety of the Senseonics’ implantable, 90-day Eversense CGM system. Eversense CGM measurements will be compared to a...
Mar 9, 2016 | Research News
This is an exciting bit of news from the Harvard Stem Cell Institute, as reported in Gizmag magazine, 22 February 2016. At the bottom is the link to the original research article published in Cell Stem Cell. Patients with Type 1 diabetes suffer from an absence of...
Mar 2, 2016 | Featured, Research News, Technology Updates
DiabetesMine is developing a new tool to help the diabetes patient community provide feedback on the tools and services available to us now. The idea is to allow the community to rate everything – from BG measuring devices to apps to nutrition and coaching programs –...
Jan 31, 2016 | Featured, Research News
Finerenone, undergoing 2 clinical trials for safety and efficacy, is a new medication developed by Bayer that may help reduce markets of kidney malfunction called “proteinuria” (the presence of abnormal quantities of protein in the urine). Read more on DiaTribe.org:...
Nov 16, 2015 | Research News
I find this area of research so very interesting … and can hardly wait til we learn more. According to Ginger Vieira of DiabetesDaily (www.diabetesdaily.com), Type 1 and Type 2 diabetes may be linked to the bacteria in your gut. What we eat impacts every part...
Oct 16, 2015 | Featured, Research News
According to a New York Times article this week, a study, published in the Annals of Internal Medicine, people with Type 2 diabetes may benefit from a daily glass of wine, a study says. Israeli researchers randomly assigned 224 patients, all alcohol abstainers with...